The Ritedose Corporation is a pharmaceutical company specializing in blow-fill-seal (BFS) manufacturing and outsourcing solutions that has been based in Columbia, South Carolina for 25 years. BFS is a process in which plastic containers are blow-molded, filled with liquid product and sealed in one continuous operation under aseptic processing conditions. The company supports pharmaceutical development and manufacturing that require BFS technology for a drug’s delivery system. Ritedose’s customers range from small startups to large pharmaceutical companies.


Ritedose is one of many manufacturers in the United States that utilize BFS equipment. Drawing on decades of experience, it has become an industry leader because of its commitment to the highest quality standards and the incorporation of operational efficiencies. Ritedose has processes and facilities that allow it to adapt quickly to customer needs.


With a new $7 million investment, Ritedose has expanded operations and employment in South Carolina with the development of the Ritedose Outsourcing Facility. This 503B facility will manufacture and deliver sterile products for hospitals and healthcare facilities throughout the United States, focusing initially on drugs that are medically necessary and for which shortages exist.
Founded in 1995, Ritedose began with 11 employees, a 52,000 sq.ft. facility, and an annual capacity of 42 million units. Today, TRC:


    • Has more than 360 employees and occupies a 120,000 sq.ft. manufacturing facility, a 153,000 sq.ft. packaging and distribution facility, and an annual capacity of 1.8 billion doses.
    • Conducts all its development, manufacturing and packaging on a 33-acre campus in Richland County, South Carolina.
    • Produces 99 percent of its products for U.S. customers.
    • Has been noted for an excellent compliance record by regulators, which include the U.S. Food & Drug Administration, State Boards of Pharmacy, U.S. Pharmacopeia, and the National Association of Boards of Pharmacy.
    • Has delivered more than 6 billion doses of drugs since 2012 without a single recall.
Ritedose occupies a 33-acre campus in Richland County, South Carolina and is dedicated to the local community where it operates.


Ritedose provides financial support and volunteers to local organizations such as Homeless No More, Epworth Children’s Home, Ronald McDonald House and Harvest Hope Food Bank.


As Columbia and the nation have grappled with the COVID-19 pandemic, Ritedose has worked to support its employees as well as the individuals and families impacted by the public health and economic crises. It has:


    • Supplied 1,500 bottles of hand sanitizer to employees of local hospitals and frontline workers.
    • Deployed three 3D printers operating 24/7 to make and donate more than 65,000 ear-savers for front line healthcare workers to use when wearing masks.
    • Provided special compensation to employees to help address economic challenges.
Jody Chastain is President and CEO of The Ritedose Corporation. Originally from Liberty, South Carolina, Jody joined Ritedose, formally Holopack International in January 2005. Prior to becoming Chief Executive in 2018, he managed supply chain and became Vice President of Operations and COO at Ritedose. Jody has a Bachelor of Science in Business Administration and Management from Limestone College in Gaffney, South Carolina, and has completed the Executive Development Program at Northwestern University’s Kellogg School of Management. Before his time at Ritedose, Jody spent 10 years working for Fujifilm in Greenwood, South Carolina. When not working Jody enjoys spending time with his wife of over 25 years and family.



  • 1995

    TRC (formerly Holopack International) founded in Columbia SC

  • 2000

    TRC receives FDA approval to manufacture & distribute drug products

  • 2003

    TRC obtains first ANDA

  • 2005

    Installation of Rommelag 460 and automated packaging line with operating capacity of 500 million units

  • 2008

    TRC obtains second ANDA and increases operating capacity to 700 million units

  • 2009

    Olympus Partners acquires Holopack International and forms The Ritedose Corporation

  • 2012

    TRC launches Ritedose Pharmaceuticals (RDP) and obtains third ANDA

  • 2013

    EU compliant expansion Quality & Development Lab expansion

  • 2016

    TRC obtains fourth ANDA and operating capacity reaches 2.1 billion units with 10 BFS machines, five fully automated packaging lines and one semi-automated packaging line

  • 2018

    Plant expansion of over 150,000 sq ft for packaging and distribution

  • 2019

    TRC registers with FDA as a 503B Outsourcing and Repackaging Facility

  • 2021

    Commercial launch of 503B Outsourcing Facility

  • 2022

    Novo Holdings acquires The Ritedose Corporation and fully automated packaging lines increased to six

Copyright © 2022 The Ritedose Corporation. All rights reserved.